Holen Sie sich die Stockscreener-App
51.81
0.01%
0.00
Schlusskurs vom Vortag:
$51.81
Offen:
$51.83
24-Stunden-Volumen:
2.04M
Relative Volume:
0.67
Marktkapitalisierung:
$7.98B
Einnahmen:
$3.23B
Nettoeinkommen (Verlust:
$889.30M
KGV:
9.8656
EPS:
5.2516
Netto-Cashflow:
$710.90M
1W Leistung:
+0.03%
1M Leistung:
+0.51%
6M Leistung:
+19.50%
1J Leistung:
+42.90%
1-Tages-Spanne:
$51.78
$51.83
1-Wochen-Bereich:
$51.70
$51.85
52-Wochen-Spanne:
$35.56
$53.76
Janus Henderson Group Plc Stock (JHG) Company Profile
Firmenname
Janus Henderson Group Plc
Sektor
Branche
Telefon
442078181818
Adresse
201 BISHOPSGATE, LONDON
Compare JHG vs BLK, BX, BN, KKR, BAM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JHG
Janus Henderson Group Plc
|
51.81 | 7.98B | 3.23B | 889.30M | 710.90M | 5.2516 |
BLK
Blackrock Inc
|
1,076.84 | 166.57B | 26.28B | 6.75B | 3.76B | 38.77 |
BX
Blackstone Inc
|
117.34 | 144.76B | 14.88B | 6.10B | 869.79M | 3.8977 |
BN
Brookfield Corp
|
45.78 | 101.34B | 77.61B | 4.06B | -8.36B | 0.497 |
KKR
Kkr Co Inc
|
94.14 | 84.44B | 22.38B | 5.74B | 8.54B | 2.9339 |
BAM
Brookfield Asset Management Ltd
|
48.92 | 76.53B | 5.07B | 2.48B | 2.37B | 1.5532 |
Janus Henderson Group Plc Stock (JHG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-04-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-01-06 | Hochstufung | Goldman | Sell → Neutral |
| 2024-09-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-09 | Hochstufung | UBS | Sell → Neutral |
| 2024-05-15 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-02-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-01-05 | Eingeleitet | UBS | Sell |
| 2024-01-04 | Eingeleitet | TD Cowen | Market Perform |
| 2023-11-06 | Hochstufung | CLSA | Underperform → Outperform |
| 2023-05-08 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2022-12-15 | Eingeleitet | Wells Fargo | Underweight |
| 2022-10-19 | Fortgesetzt | Credit Suisse | Underperform |
| 2022-10-05 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2022-09-07 | Fortgesetzt | BofA Securities | Neutral |
| 2022-07-29 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-07-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-06-29 | Herabstufung | Keefe Bruyette | Mkt Perform → Underperform |
| 2022-02-04 | Herabstufung | Macquarie | Outperform → Neutral |
| 2021-07-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-01-05 | Herabstufung | Goldman | Neutral → Sell |
| 2020-10-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2020-05-01 | Hochstufung | Goldman | Sell → Neutral |
| 2020-05-01 | Hochstufung | Keefe Bruyette | Underperform → Mkt Perform |
| 2020-02-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-05 | Hochstufung | Macquarie | Neutral → Outperform |
| 2020-02-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-01-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-01-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2019-12-05 | Eingeleitet | Evercore ISI | In-line |
| 2019-10-04 | Herabstufung | Keefe Bruyette | Mkt Perform → Underperform |
| 2019-07-22 | Herabstufung | Jefferies | Buy → Hold |
| 2019-05-03 | Herabstufung | Goldman | Neutral → Sell |
| 2019-05-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2019-03-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-24 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2018-08-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-08-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-04-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-04-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
Alle ansehen
Janus Henderson Group Plc Aktie (JHG) Neueste Nachrichten
Janus Henderson European Focus Fund Q1 2026 Commentary - Seeking Alpha
Janus Henderson Concentrated Growth Managed Account Q1 2026 Commentary - Seeking Alpha
Janus Henderson Concentrated All Cap Growth Managed Account Q1 2026 Commentary - Seeking Alpha
Behavioral Patterns of JHG and Institutional Flows - Stock Traders Daily
Janus Mortgage-Backed Securities ETF Q1 2026 Commentary (NYSEARCA:JMBS) - Seeking Alpha
Janus Henderson U.S. Real Estate ETF Q1 2026 Commentary (NYSEARCA:JRE) - Seeking Alpha
JHG Technical Analysis | Trend, Signals & Chart Patterns | JANUS HENDERSON GROUP PLC (NYSE:JHG) - ChartMill
Dan Aronson Janus Henderson - Wealth Management
Janus Henderson Small-Mid Cap Value Fund Q1 2026 Commentary (JVSAX) - Seeking Alpha
Is Victory Capital's New Bid a Game Changer for Janus Henderson - Kavout
Janus Henderson Small Cap Value Fund Q1 2026 Commentary - Seeking Alpha
Janus Henderson Mid Cap Value Fund Q1 2026 Commentary (JDPAX) - Seeking Alpha
Janus Henderson expands active ETF push with seven LSE listings - QuotedData
Janus Henderson Investor Survey Reveals How Investors View AI: As an Investment Theme and for Financial Guidance - Business Wire
Janus Henderson International Dividend Fund Q1 2026 Commentary - Seeking Alpha
MSN Money - MSN
Janus Henderson (JHG) amends 13F reporting $209.4B in holdings - Stock Titan
GABELLI & Co INVESTMENT ADVISERS INC. Makes New Investment in Janus Henderson Group plc $JHG - MarketBeat
Janus Henderson Global Technology And Innovation Fund Q1 2026 Commentary (JATIX) - Seeking Alpha
Billionaire Nelson Peltz plans AI makeover for Janus Henderson - MSN
Janus Henderson (DRUG) discloses 1.28M shares, 13.1% stake - Stock Titan
[SCHEDULE 13G/A] Biohaven Ltd. Amended Passive Investment Disclosure - Stock Titan
Janus Henderson (TYRA) discloses 3.89M shares; 7.2% stake (Schedule 13G/A) - Stock Titan
Janus Henderson Group (NASDAQ: PTCT) holds 8.7% of PTC Therapeutics (7.19M shares) - Stock Titan
Janus Henderson (TARA) disclosed 5.21M-share, 9.6% stake in Protara - Stock Titan
Janus Henderson (NASDAQ: OLMA) discloses 7.11M shares, 8.2% stake - Stock Titan
Janus Henderson (LNTH) holds 4.77M shares of Lantheus, 7.4% stake disclosed - Stock Titan
Janus Henderson (JANX) discloses 4.2M shares, 6.9% passive stake - Stock Titan
Janus Henderson (IMMX) reports 4.8M shares, 9.1% stake disclosed - Stock Titan
Janus Henderson (PCVX) discloses 16.6M shares, 11.5% ownership - Stock Titan
Janus Henderson (MAZE) discloses 2.86M shares, a 5.8% stake - Stock Titan
Janus Henderson (MDGL) discloses 2,018,647-share stake, 8.8% ownership - Stock Titan
Janus Henderson holds 7.27M IDEAYA shares (NASDAQ: IDYA) - Stock Titan
Janus Henderson Group (GKOS) discloses 5.35M shares, 9.2% holding - Stock Titan
Janus Henderson (NYSE: GIL) discloses 10,593,203 Gildan shares, 5.7% - Stock Titan
Janus Henderson (FBRX) discloses 9.99% holding; 299,798 pre-funded warrants - Stock Titan
Janus Henderson reports 13.65M shares in Dyne Therapeutics (NASDAQ: DYN) - Stock Titan
Janus Henderson Group (DRUG) discloses 1.28M shares, 13.1% stake - Stock Titan
Janus Henderson (BBIO) discloses 13,179,013 shares, 6.8% ownership - Stock Titan
Janus Henderson (BELFA) discloses 760,141 Class B shares, 7.2% stake - Stock Titan
Janus Henderson (NASDAQ: ASND) reports 3.72M ADS stake - Stock Titan
Janus Henderson (NERV) reports 4.3M shares, 9.9% stake disclosed - Stock Titan
[SCHEDULE 13G] Longeveron Inc. Passive Investment Disclosure (>5%) - Stock Titan
Janus Henderson holds 2.24M shares in Tarsus Pharmaceuticals (TARS) - Stock Titan
Janus Henderson (LRN) reports 2.28M shares, 5.4% stake in Stride (03/31/2026) - Stock Titan
Janus Henderson (EWTX) reports 5.5% ownership — 5.9M shares disclosed - Stock Titan
Janus Henderson (COLL) reports 1.83M-share, 5.8% holding in PHARMACEUTICAL, INC. - Stock Titan
Janus Henderson (DAY) Amendment: Asset Managers report 0 shares - Stock Titan
Janus Henderson (ARDX) discloses 8.37M‑share, 3.4% position in Ardelyx - Stock Titan
Janus Henderson (LON: JHG) discloses 772,314-share stake in OSI Systems (4.7%) - Stock Titan
Janus Henderson Group reports stake in Revolution Medicines (RVMD) — 9.77M shares - Stock Titan
Finanzdaten der Janus Henderson Group Plc-Aktie (JHG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):